RPM International Surges 10.2% After Reporting Better-than-Expected Earnings
PorAinvest
jueves, 24 de julio de 2025, 10:42 am ET1 min de lectura
ARAI--
West Pharmaceutical Services Inc. (WST) also reported strong quarterly results, with adjusted EPS of $1.84, up from $1.52 a year ago. This exceeded the mean expectation of analysts, who had forecast EPS of $1.51. Revenue rose 9.2% to $766.50 million, surpassing the expected $727.45 million. The company's quarterly net income was $131.8 million. Shares of West Pharmaceutical Services Inc. rose by 3.9% this quarter and lost 30.6% so far this year. Analysts have a "buy" rating with 11 "strong buy" or "buy" recommendations, 4 "hold" recommendations, and no "sell" recommendations. The median 12-month price target for WST is $273.50, up 16.9% from the last closing price of $227.31 [2].
These positive results come amidst a broader market trend where several other major stocks, including ICON, Bloom Energy, MaxLinear, ASGN Incorporated, Arrive AI, Solid Power, MicroVision, TMC the metals company, Labcorp Holdings, TechnipFMC, Deutsche Bank Aktiengesellschaft, Charles River Laboratories International, FirstService Corporation, Nasdaq, T-Mobile US, and Jim Cramer, have also shown gains.
References:
1. [1] https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3TL1KU:0-rpm-international-inc-reports-results-for-the-quarter-ended-may-31-earnings-summary/
2. [2] https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3TL1KK:0-west-pharmaceutical-services-inc-reports-results-for-the-quarter-ended-june-30-earnings-summary/
ASGN--
BE--
CRL--
DB--
RPM International reported better-than-expected quarterly EPS and sales, with shares jumping 10.2% to $124.46. Other big stocks recording gains include West Pharmaceutical Services, ICON, Bloom Energy, MaxLinear, ASGN Incorporated, Arrive AI, Solid Power, MicroVision, TMC the metals company, Labcorp Holdings, TechnipFMC, Deutsche Bank Aktiengesellschaft, Charles River Laboratories International, FirstService Corporation, Nasdaq, T-Mobile US, and Jim Cramer.
RPM International Inc. (RPM) reported better-than-expected quarterly earnings and revenue, with adjusted earnings per share (EPS) of $1.72, up from $1.56 a year ago. This figure exceeded the mean expectation of analysts, who had forecast EPS of $1.59. Revenue rose 3.7% to $2.08 billion, surpassing the expected $2.01 billion. The company's quarterly net income was $225.51 million. Shares of RPM International Inc. rose by 2.8% this quarter and lost 8.2% so far this year. Analysts have a "buy" rating with 10 "strong buy" or "buy" recommendations, 7 "hold" recommendations, and 1 "sell" recommendation. The median 12-month price target for RPM is $124.00, up 8.9% from the last closing price of $112.95 [1].West Pharmaceutical Services Inc. (WST) also reported strong quarterly results, with adjusted EPS of $1.84, up from $1.52 a year ago. This exceeded the mean expectation of analysts, who had forecast EPS of $1.51. Revenue rose 9.2% to $766.50 million, surpassing the expected $727.45 million. The company's quarterly net income was $131.8 million. Shares of West Pharmaceutical Services Inc. rose by 3.9% this quarter and lost 30.6% so far this year. Analysts have a "buy" rating with 11 "strong buy" or "buy" recommendations, 4 "hold" recommendations, and no "sell" recommendations. The median 12-month price target for WST is $273.50, up 16.9% from the last closing price of $227.31 [2].
These positive results come amidst a broader market trend where several other major stocks, including ICON, Bloom Energy, MaxLinear, ASGN Incorporated, Arrive AI, Solid Power, MicroVision, TMC the metals company, Labcorp Holdings, TechnipFMC, Deutsche Bank Aktiengesellschaft, Charles River Laboratories International, FirstService Corporation, Nasdaq, T-Mobile US, and Jim Cramer, have also shown gains.
References:
1. [1] https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3TL1KU:0-rpm-international-inc-reports-results-for-the-quarter-ended-may-31-earnings-summary/
2. [2] https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3TL1KK:0-west-pharmaceutical-services-inc-reports-results-for-the-quarter-ended-june-30-earnings-summary/

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios